Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates

類似資料

• Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
  著者:: Geisbert, Thomas W., 等
  出版事項: (2011)
• Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
  著者:: Sullivan, Nancy J, 等
  出版事項: (2006)
• Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
  著者:: Geisbert, Thomas W., 等
  出版事項: (2009)
• Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
  著者:: Woolsey, Courtney, 等
  出版事項: (2018)
• Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection
  著者:: Geisbert, Thomas W., 等
  出版事項: (2015)